IM Cannabis Corp. (the "Company" or "IMC") (NASDAQ: IMCC) (CSE: IMCC), an international medical cannabis company, is pleased to announce its financial results for the fourth quarter and year ended ...

IM Cannabis: 66% Revenue Growth In Germany, Narrows EBITDA Loss In Q3 International medical cannabis company IM Cannabis Corp. (NASDAQ: IMCC) (CSE: IMCC) announced on Thursday its financial ...

IM Cannabis Corp (NASDAQ:IMCC) experienced extraordinary growth in the German market following partial legalization in April 2024. The company reduced operating expenses by 53% since 2022 ...

Good morning and welcome to IM Cannabis' Fourth Quarter and Full Year 2024 Earnings Conference Call. Today's conference call is being recorded. At this time, I would like to turn the conference ...